Ciprofloxacin Hydrochloride; Hydrocortisone Patent Expiration

Ciprofloxacin Hydrochloride; Hydrocortisone is Used for treating otitis. It was first introduced by Sandoz Inc in its drug Cipro Hc on Feb 10, 1998.


Ciprofloxacin Hydrochloride; Hydrocortisone Patents

Given below is the list of patents protecting Ciprofloxacin Hydrochloride; Hydrocortisone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cipro Hc US5843930 Method of treating otitis with ciprofloxacin-hydrocortisone suspension Jun 06, 2015

(Expired)

Sandoz
Cipro Hc US5965549 Ciprofloxacin-hydrocortisone suspension Jun 06, 2015

(Expired)

Sandoz



Ciprofloxacin Hydrochloride; Hydrocortisone's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List